Javier Rodriguez
Chief Executive Officer at DaVita Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Gilead Sciences Inc., 3 years.
Gilead Sciences Inc.
Director
DaVita Inc.
Director · Chief Executive Officer
Chief executive roles
DaVita Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | DaVita Inc. | Open-market sale | −39,407 | $209.28 | $8,247,097 |
| Jun 15, 2026 | DaVita Inc. | Open-market sale | −30,000 | $209.50 | $6,285,000 |
| Apr 30, 2026 | Gilead Sciences Inc. | Grant or award | +1,146 | — | — |
| Mar 15, 2026 | DaVita Inc. | Grant or award | +20,900 | — | — |
| Nov 15, 2025 | DaVita Inc. | Shares withheld for tax | −5,165 | $121.55 | $627,806 |
| May 7, 2025 | Gilead Sciences Inc. | Grant or award | +1,516 | — | — |
| Mar 15, 2025 | DaVita Inc. | Grant or award | +18,822 | — | — |
| Nov 15, 2024 | DaVita Inc. | Grant or award | +37,423 | — | — |
| Sep 16, 2024 | DaVita Inc. | Open-market sale | −50,000 | $165.05 | $8,252,500 |
| Sep 13, 2024 | DaVita Inc. | Open-market sale | −9,881 | $162.85 | $1,609,121 |
| Aug 27, 2024 | DaVita Inc. | Open-market sale | −7,943 | $155.93 | $1,238,552 |
| Aug 26, 2024 | DaVita Inc. | Open-market sale | −32,176 | $155.93 | $5,017,204 |
| Aug 20, 2024 | DaVita Inc. | Option exercise | +750,000 | $67.80 | $50,850,000 |
| Aug 20, 2024 | DaVita Inc. | Sold back to the company | −334,166 | $152.17 | $50,850,040 |
| Aug 20, 2024 | DaVita Inc. | Shares withheld for tax | −181,928 | $152.17 | $27,683,984 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.